A non-traditional therapeutic strategy in management of fulminant hepatic failure: histopathological and immunohistochemistry study

Journal Title: Journal of Drug Discovery and Therapeutics - Year 2014, Vol 2, Issue 1

Abstract

The present study was undertaken to evaluate the crucial role of hepatocytes transplantation in experimental model of D-galactosamine induced fulminating hepatic failure (FHF) in rat. Hepatocytes were isolated and grown from a group of apparently healthy rats. The isolated hepatocyte were characterized and cultured in vitro and transplanted in FHF rat models either alone or with cyclosporine as immunosuppressive agent. The isolated hepatocytes were cultured for 24 hours prior transplantation in the peritoneal cavity in each of infected (FHF) rat. It was observed that the high survival rate and the improvement of the liver function parameters among transplanted groups versus the non-treated ones. Histopathological and immunehistochemistry data revealed the presence of hepatocytes attached to the peritoneal covering of the abdominal organs in either a single or several layers.

Authors and Affiliations

Farid A. Badria*| Department of Pharmacognosy, Faculty of Pharmacy, Mansoura University, Mansoura 35516, EGYPT, Atallah F. Ahmed| Department of Pharmacognosy, Faculty of Pharmacy, Mansoura University, Mansoura 35516, EGYPT, Wael M. Elsaed| Department of Anatomy and Embryology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, EGYPT, Omar M. Gabre| Department of Anatomy and Embryology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, EGYPT, Kamal G. Botros| Department of Anatomy and Embryology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, EGYPT

Keywords

Related Articles

INDUSTRIAL PROCESS VALIDATION OF TABLETS: AN OVERVIEW

The validation is a Fundamental segment to support the commitment of company towards quality assurance. It also assures that product meets its predetermined quality specification and quality characteristics. Validation o...

PHARMACEUTICAL TASTE MASKING TECHNOLOGIES OF BITTER DRUGS: A CONCISE REVIEW

Taste refers to a perception arising from the stimulation of taste buds present on the surface of the tongue. Humans can distinguish among five components of taste: sourness, saltiness, sweetness, bitterness, and umami (...

IMMUNE RESPONSE DRUG CONJUGATES: CARBON-14 LABELING NECESSITIES

Despite recent advances in early detection and treatment, prostate cancer is the most common cancer and the second leading cause of cancer-related deaths in developed countries. Prostate cancer patients having a limited...

FORMULATION DEVELOPMENT AND EVALUATION OF SUSTAINED RELEASE OXCARBAZEPINE TABLET

The Sustained release drug delivery systems that are designed to achieve or extend therapeutic effect by continuously releasing medication over an extended period of time after administration of a single dose, to individ...

TREATMENT AND MANAGEMENT OF DIABETES WITH STEM CELL THERAPY: A NEWER SCIENTIFIC APPRAOCH

Diabetes is usually a lifelong (chronic) disease in which there are high levels of sugar in the blood. Diabetes, often referred to by doctors as diabetes mellitus, describes a group of metabolic diseases in which the per...

Download PDF file
  • EP ID EP1466
  • DOI -
  • Views 396
  • Downloads 26

How To Cite

Farid A. Badria*, Atallah F. Ahmed, Wael M. Elsaed, Omar M. Gabre, Kamal G. Botros (2014). A non-traditional therapeutic strategy in management of fulminant hepatic failure: histopathological and immunohistochemistry study. Journal of Drug Discovery and Therapeutics, 2(1), 40-52. https://europub.co.uk/articles/-A-1466